NCT01339442
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +6 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Clinical trial condition
Estrogen Receptor-positive Breast Cancer
Explore clinical trials studying Estrogen Receptor-positive Breast Cancer. Study availability and eligibility vary by location and protocol.
28 public trials
2 recruiting studies
Estrogen Receptor-positive Breast Cancer trial results
NCT00952731
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +8 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT00057941
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +7 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
Active, Not Recruiting
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
NCT02957968
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +17 more
- Locations
-
- St. Elizabeth Healthcare Edgewood, Kentucky, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- University of Virginia Charlottesville, Virginia, United States
- Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States
Active, Not Recruiting
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
NCT01953588
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Personalised Disease Monitoring in Metastatic Breast Cancer
NCT04597580
- Conditions
- Breast Cancer Metastatic, Breast Diseases, Breast Neoplasms, +9 more
- Locations
-
- Department of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden
- Department of Oncology, Ryhov Hospital Jönköping, Sweden
- Department of Oncology, Kalmar Hospital Kalmar, Sweden
- Department of Oncology, Linköping University Hospital Linköping, Sweden
Active, Not Recruiting
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
NCT01824836
- Conditions
- Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +13 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
- Veterans Adminstration New Jersey Health Care System East Orange, New Jersey, United States
Active, Not Recruiting
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer
NCT01791478
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +16 more
- Locations
-
- Massachusetts General Hospital, Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States